Parkinson's disease genes do not segregate with breast cancer genes' loci

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 8, 2013, Pages 1464-1472

  Kravitz, Efrat ^a,b   Laitman, Yael ^c   Hassin Baer, Sharon ^a,d   Inzelberg, Rivka ^a,b,d   Friedman, Eitan ^c,d  

^a Parkinson Disease and Movement Disorders Clinic   (United States)

^b Joseph Sagol Neuroscience Center   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DJ 1 PROTEIN; LEUCINE RICH REPEAT KINASE 2; PARK2 PROETEIN; PINK1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CHROMOSOME; CHROMOSOME 1; CHROMOSOME 12; CHROMOSOME 4; CHROMOSOME 6; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

BREAST NEOPLASMS; DATA MINING; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84882269119     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0472     Document Type: Article

References (41)

1. Rugbjerg K, Friis S, Lassen CF, Ritz B, Olsen JH. Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease. Int J Cancer 2012;131:1904-11.
2. Inzelberg R, Cohen OS, Aharon-Peretz J, Schlesinger I, Gershoni-Baruch R, Djaldetti R, et al. The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers. Neurology 2012;78:781-6.
3. Inzelberg R, Jankovic J. Are Parkinson disease patients protected from some but not all cancers? Neurology 2007;69: 1542-50.
4. Ji H, Liu YE, Jia T, Wang M, Liu J, Xiao G, et al. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res 1997;57:759-64.
5. PubMed [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2005 [Updated 2012 Apr 26]. Available from: Http://www.ncbi.nlm.nih.gov/.
6. Hindorff LA, MacArthur J, Morales J (European Bioinformatics Institute), Junkins HA, Hall PN, Klemm AK, et al. A catalog of published genome-wide association studies; [Accessed 2012 Jun 30]. Available from: Www.genome.gov/gwastudies.
7. Breast Cancer Association Consortium (BCAC) [Internet]. Cambridge, UK: Cambridge (UK) Publication Catalog; [Accessed 2012 Jun 30]. Available from: Http://ccge.medschl.cam.ac.uk/consortia/bcac/pubs/pubs.html.
8. NCBI [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2005 [Updated 2012 Apr 26; accessed 2012 July 31]. Available from: Http://www.ncbi.nlm.nih.gov/projects/sviewer/.
9. Gao X, Simon KC, Han J, Schwarzschild MA, Ascherio A. Family history of melanoma and Parkinson disease risk. Neurology 2009;73: 1286-91.
10. Kong X, Li G, Yuan Y, He Y, Wu X, Zhang W, et al. MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression. PLoS ONE 2012;7:e41523.
11. Liu B, Dluzen DE. Oestrogen and nigrostriatal dopaminergic neurodegeneration: Animal models and clinical reports of Parkinson's disease. Clin Exp Pharmacol Physiol 2007;34:555-65.
12. Latourelle JC, Dybdahl M, Destefano AL, Myers RH, Lash TL. Risk of Parkinson's disease after tamoxifen treatment. BMC Neurol 2010; 10:23.
13. Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, et al. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res 2012;14:R33.
14. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, et al. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 2012;44:312-8.
15. Long J, Cai Q, Sung H, Shi J, Zhang B, Choi JY, et al. Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet 2012;8:e1002532.
16. Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, Walker K, et al. Novel breast cancer susceptibility locus at 9q31.2: Results of a genome-wide association study. J Natl Cancer Inst 2011;103: 425-35.
17. Hutter CM, Young AM, Ochs-Balcom HM, Carty CL, Wang T, Chen CT, et al. Replication of breast cancer GWAS susceptibility loci in the Women's Health Initiative African American SHARe Study. Cancer Epidemiol Biomarkers Prev 2011;20:1950-9.
18. Li J,Humphreys K, Heikkinen T, Aittomaki K, Blomqvist C, Pharoah PD, et al. A combined analysis of genome-wide association studies in breast cancer. Breast Cancer Res Treat 2011;126:717-27.
19. Loizidou MA, Hadjisavvas A, Ioannidis JP, Kyriacou K. Replication of genome-wide discovered breast cancer risk loci in the Cypriot population. Breast Cancer Res Treat 2011;128:267-72.
20. Sehrawat B, Sridharan M, Ghosh S, Robson P, Cass CE, Mackey JR, et al. Potential novel candidate polymorphisms identified in genomewide association study for breast cancer susceptibility. Hum Genet 2011;130:529-37.
21. Stevens KN, Vachon CM, LeeAM, Slager S, Lesnick T, Olswold C, et al. Common breast cancer susceptibility loci are associated with triplenegative breast cancer. Cancer Res 2011;71:6240-9.
22. Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptornegative breast cancer in the general population. Nat Genet 2010;42: 885-92.
23. Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, et al. Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Genet 2010;6:e1001183.
24. Long J, Cai Q, Shu XO, Qu S, Li C, Zheng Y, et al. Identification of a functional genetic variant at 16q12.1 for breast cancer risk: Results from the Asia Breast Cancer Consortium. PLoS Genet 2010;6:e1001002.
25. Stacey SN, Sulem P, Zanon C, Gudjonsson SA, Thorleifsson G, Helgason A, et al. Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet 2010;6:e1001029.
26. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 2010;42:504-7.
27. Walker LC, Fredericksen ZS, Wang X, Tarrell R, Pankratz VS, Lindor NM, et al. Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers. Breast Cancer Res 2010;12:R102.
28. WangX, Pankratz VS, Fredericksen Z, Tarrell R, Karaus M, McGuffog L, et al. Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 2010;19:2886-97.
29. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 2009;41:585-90.
30. Dunning AM, Healey CS, Baynes C, Maia AT, Scollen S, Vega A, et al. Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 2009;18:1131-9.
31. Mavaddat N, Dunning AM, Ponder BA, Easton DF, Pharoah PD. Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. Cancer Epidemiol Biomarkers Prev 2009;18:255-9.
32. Saetrom P, Biesinger J, Li SM, Smith D, Thomas LF, Majzoub K, et al. A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res 2009;69:7459-65.
33. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 2009;41:579-84.
34. Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 2009;41:324-8.
35. Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J, et al. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A 2008;105: 4340-5.
36. Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, et al.A commoncoding variant inCASP8 is associated with breast cancer risk. Nat Genet 2007;39:352-8.
37. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007;447:1087-93.
38. Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA, Titus-Ernstoff L, et al. Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet 2007;121:483-90.
39. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007;39:870-4.
40. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al. Commonvariants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2007;39:865-9.
41. Breast Cancer Association Consortium. Commonly studied singlenucleotide polymorphisms and breast cancer: Results from the Breast Cancer Association Consortium. J Natl Cancer Inst 2006;98: 1382-96.